Vutrisiran Reduces Days Lost To Death And/or Hospitalization Versus Placebo In Patients With Transthyretin Amyloidosis With Cardiomyopathy In The HELIOS-B Trial

Journal of Cardiac Failure 2026

View at publisher

Authors: Ali Yılmaz, Ainara Lozano Bahamonde, Nicolas Lamblin, Hiroaki Kitaoka, Emre Aldinc, David Danese, Shaun D. Bender, Mazen A Hanna

DOI: 10.1016/j.cardfail.2025.11.038

Cited by: 0

Fields of Study & Subjects

Amyloidosis: Diagnosis Treatment Outcomes Heart Failure Treatment and Management Alzheimer's disease research and treatments